GLRA1 and hyperekplexia: A point mutation in the murine Glra1 locus, which selectively suppresses Zn potentiation, generates a phenotype that mimics that of patients with hyperekplexia (hereditary startle disease) and thus is indicative of decreased glycinergic inhibition (Betz and Laube 2006).